Administration Of Dry Powder Formulation Of Insulin By Inhalation

Abstract: A method of preparation a formulation in the form of dry powder such formulation essentially free of absorption enhancers and capable of encapsulated in a capsule body or the like construction for administration by inhalation comprising forming a primary ingredient comprising insulin or its analogue, such as, insulin lispro, insulin aspart, insulin glargine or insulin detemir, in which the size of aerosolized particles is less than 5 microns, preferably less than 2 microns and is releasable within an inhaler device.

Patent Information

Application #

Filing Date

05 November 1999

Publication Number

13/2007

Publication Type

INA

Invention Field

PHARMACEUTICALS

Status

Email

Parent Application

Applicants

CIPLA LIMITED

289, BELLASIS ROAD, MUMBAI CENTRAL, MUMBAI-400 008,

Inventors

1. AMAR LULLA

CIPLA LIMITED 289, BELLASIS ROAD, MUMBAI CENTRAL, MUMBAI-400 008,

2. GEENA MALHOTRA

CIPLA LIMITED 289, BELLASIS ROAD, MUMBAI CENTRAL, MUMBAI-400 008,

Specification

Documents

Application Documents

#	Name	Date
1	775-bom-1999-cancelled pages.pdf	2018-08-08
1	775-bom-1999-specification(amended).pdf	2018-08-08
2	775-bom-1999-correspondence(ipo).pdf	2018-08-08
2	775-bom-1999-forms.pdf	2018-08-08
3	775-bom-1999-correspondence(received).pdf	2018-08-08
3	775-bom-1999-form 2(provisional).pdf	2018-08-08
4	775-bom-1999-form 2(complete).pdf	2018-08-08
5	775-bom-1999-correspondence(received).pdf	2018-08-08
5	775-bom-1999-form 2(provisional).pdf	2018-08-08
6	775-bom-1999-correspondence(ipo).pdf	2018-08-08
6	775-bom-1999-forms.pdf	2018-08-08
7	775-bom-1999-cancelled pages.pdf	2018-08-08
7	775-bom-1999-specification(amended).pdf	2018-08-08